Efficacy, Safety, and Pharmacokinetics of Upadacitinib Among Patients in East Asia With Moderately to Severely Active Ulcerative Colitis: A Post Hoc Subanalysis of Randomized Phase 3 Studies.
- DOI
- 10.1111/jgh.70634
- Published
- 2026 Sep
- Container
- Journal of gastroenterology and hepatology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1111/jgh.70634,
title = {Efficacy, Safety, and Pharmacokinetics of Upadacitinib Among Patients in East Asia With Moderately to Severely Active Ulcerative Colitis: A Post Hoc Subanalysis of Randomized Phase 3 Studies.},
author = {Wei SC and Nakase H and Ye BD and Chao K and Wu HY and Eccleston J and Yao X and Palac H and Mohamed MF and Ponce-Bobadilla AV and Suravaram S and Barrachina EM and Hisamatsu T and Gao X},
year = {2026},
journal = {Journal of gastroenterology and hepatology},
doi = {10.1111/jgh.70634},
url = {https://doi.org/10.1111/jgh.70634}
}RIS
TY - JOUR TI - Efficacy, Safety, and Pharmacokinetics of Upadacitinib Among Patients in East Asia With Moderately to Severely Active Ulcerative Colitis: A Post Hoc Subanalysis of Randomized Phase 3 Studies. AU - Wei SC AU - Nakase H AU - Ye BD AU - Chao K AU - Wu HY AU - Eccleston J AU - Yao X AU - Palac H AU - Mohamed MF AU - Ponce-Bobadilla AV AU - Suravaram S AU - Barrachina EM AU - Hisamatsu T AU - Gao X PY - 2026 JO - Journal of gastroenterology and hepatology DO - 10.1111/jgh.70634 UR - https://doi.org/10.1111/jgh.70634 ER -
APA
SC, W., H, N., BD, Y., K, C., HY, W., J, E., X, Y., H, P., MF, M., AV, P., S, S., EM, B., T, H., & X, G. (2026). Efficacy, Safety, and Pharmacokinetics of Upadacitinib Among Patients in East Asia With Moderately to Severely Active Ulcerative Colitis: A Post Hoc Subanalysis of Randomized Phase 3 Studies.. Journal of gastroenterology and hepatology. https://doi.org/10.1111/jgh.70634
Source records
- pubmed · retrieved 2026-09-25T15:34:06.197Z